Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aptevo Therapeutics (APVO) Net Margin (2016 - 2022)

Historic Net Margin for Aptevo Therapeutics (APVO) over the last 8 years, with Q1 2022 value amounting to 5.72%.

  • Aptevo Therapeutics' Net Margin fell 113800.0% to 5.72% in Q1 2022 from the same period last year, while for Dec 2022 it was 32.53%, marking a year-over-year increase of 247900.0%. This contributed to the annual value of 32.53% for FY2022, which is 247900.0% up from last year.
  • Per Aptevo Therapeutics' latest filing, its Net Margin stood at 5.72% for Q1 2022, which was down 113800.0% from 8.87% recorded in Q4 2021.
  • In the past 5 years, Aptevo Therapeutics' Net Margin registered a high of 57.26% during Q3 2019, and its lowest value of 1439.11% during Q2 2020.
  • Over the past 5 years, Aptevo Therapeutics' median Net Margin value was 4.24% (recorded in 2021), while the average stood at 109.53%.
  • As far as peak fluctuations go, Aptevo Therapeutics' Net Margin crashed by -12638900bps in 2020, and later surged by 14433600bps in 2021.
  • Quarter analysis of 5 years shows Aptevo Therapeutics' Net Margin stood at 0.67% in 2018, then soared by 2974bps to 20.58% in 2019, then crashed by -76bps to 4.97% in 2020, then soared by 78bps to 8.87% in 2021, then tumbled by -36bps to 5.72% in 2022.
  • Its Net Margin stands at 5.72% for Q1 2022, versus 8.87% for Q4 2021 and 2.58% for Q3 2021.